drugset / Trial / NCT01161914
The Safety and Efficacy Study of ISU302 in Patient With Type I Gaucher Disease
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to compare and evaluate the efficacy and safety of ISU302, an investigational product, and Cerezyme®, comparator, for Type 1 Gaucher Disease patients
Timeline
- Start
- 2011-01
- Primary completion
- 2011-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ISU302 | Protein / enzyme biologic | 60 iu/kg | Intravenous |
| Comparator | Imiglucerase | Protein / enzyme biologic | 60 iu/kg | Intravenous |